blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3565573

EP3565573 - PAC1 RECEPTOR AGONISTS (MAXCAPS) AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.06.2024
Database last updated on 03.09.2024
FormerThe patent has been granted
Status updated on  21.07.2023
FormerGrant of patent is intended
Status updated on  13.03.2023
FormerExamination is in progress
Status updated on  01.07.2021
FormerRequest for examination was made
Status updated on  11.10.2019
FormerThe international publication has been made
Status updated on  13.07.2018
Most recent event   Tooltip30.08.2024Lapse of the patent in a contracting state
New state(s): MC		published on 02.10.2024 [2024/40]
Applicant(s)For all designated states
The Regents of the University of California
1111 Franklin Street, 12th Floor
Oakland, CA 94607 / US
For all designated states
The United States Government Represented by the Department of Veterans Affairs
Office of the General Counsel
Washington, DC 20420 / US
[2019/46]
Inventor(s)01 / PISEGNA, Joseph R.
834 26th Street
Santa Monica, California 90403 / US
02 / GERMANO, Patrizia M.
834 26th Street
Santa Monica, California 90403 / US
03 / VU, John P.
111 Franklin St., 12th Fl.
Oakland, CA 94607-5200 / US
 [2019/47]
Former [2019/46]01 / PISEGNA, Joseph R.
834 26th Street
Santa Monica, California 90403 / US
02 / GERMANO, Patrizia M.
834 26th Street
Santa Monica, California 90403 / US
03 / VU, John P.
1437 S. Westgate Avenue, 4
Los Angeles, California 90025 / US
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2023/34]
Former [2019/46]Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
Application number, filing date18736163.904.01.2018
[2019/46]
WO2018US12405
Priority number, dateUS201762442906P05.01.2017         Original published format: US 201762442906 P
[2019/46]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2018129200
Date:12.07.2018
Language:EN
[2018/28]
Type: A2 Application without search report 
No.:EP3565573
Date:13.11.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 12.07.2018 takes the place of the publication of the European patent application.
[2019/46]
Type: B1 Patent specification 
No.:EP3565573
Date:23.08.2023
Language:EN
[2023/34]
Search report(s)International search report - published on:US09.08.2018
(Supplementary) European search report - dispatched on:EP10.07.2020
ClassificationIPC:A61K38/00, C07K14/435, C07K19/00, A61P1/16, A61P3/04, A61P3/10, C07K14/575, C07K14/705, // A61K38/22
[2020/33]
CPC:
C07K14/70503 (EP); C07K14/57563 (EP,US); A61K31/4985 (US);
A61K38/2278 (US); A61K47/60 (US); A61K47/61 (US);
A61K47/65 (US); A61P1/16 (EP); A61P3/04 (EP);
A61P3/10 (EP); C07K14/43577 (EP,US); A61K38/00 (EP,US);
C07K2319/00 (EP,US) (-)
Former IPC [2019/46]A61K38/00, C07K14/435, C07K19/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/46]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:PAC1-REZEPTOR-AGONISTEN (MAXCAPS) UND VERWENDUNGEN DAVON[2019/46]
English:PAC1 RECEPTOR AGONISTS (MAXCAPS) AND USES THEREOF[2019/46]
French:AGONISTES DU RÉCEPTEUR PAC1 (MAXCAPS) ET LEURS UTILISATIONS[2019/46]
Entry into regional phase02.07.2019National basic fee paid 
02.07.2019Search fee paid 
02.07.2019Designation fee(s) paid 
02.07.2019Examination fee paid 
Examination procedure02.07.2019Examination requested  [2019/46]
04.02.2021Amendment by applicant (claims and/or description)
30.06.2021Despatch of a communication from the examining division (Time limit: M06)
07.12.2021Reply to a communication from the examining division
13.03.2023Communication of intention to grant the patent
17.07.2023Fee for grant paid
17.07.2023Fee for publishing/printing paid
17.07.2023Receipt of the translation of the claim(s)
Opposition(s)24.05.2024No opposition filed within time limit [2024/31]
Fees paidRenewal fee
27.01.2020Renewal fee patent year 03
27.01.2021Renewal fee patent year 04
27.01.2022Renewal fee patent year 05
27.01.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT23.08.2023
CZ23.08.2023
DK23.08.2023
EE23.08.2023
ES23.08.2023
FI23.08.2023
HR23.08.2023
LT23.08.2023
LV23.08.2023
MC23.08.2023
NL23.08.2023
PL23.08.2023
RO23.08.2023
RS23.08.2023
SI23.08.2023
SK23.08.2023
SM23.08.2023
NO23.11.2023
GR24.11.2023
IS23.12.2023
PT26.12.2023
[2024/40]
Former [2024/36]AT23.08.2023
CZ23.08.2023
DK23.08.2023
EE23.08.2023
ES23.08.2023
FI23.08.2023
HR23.08.2023
LT23.08.2023
LV23.08.2023
NL23.08.2023
PL23.08.2023
RO23.08.2023
RS23.08.2023
SI23.08.2023
SK23.08.2023
SM23.08.2023
NO23.11.2023
GR24.11.2023
IS23.12.2023
PT26.12.2023
Former [2024/23]AT23.08.2023
CZ23.08.2023
DK23.08.2023
EE23.08.2023
ES23.08.2023
FI23.08.2023
HR23.08.2023
LT23.08.2023
LV23.08.2023
NL23.08.2023
PL23.08.2023
RO23.08.2023
RS23.08.2023
SK23.08.2023
SM23.08.2023
NO23.11.2023
GR24.11.2023
IS23.12.2023
PT26.12.2023
Former [2024/22]AT23.08.2023
CZ23.08.2023
DK23.08.2023
FI23.08.2023
HR23.08.2023
LT23.08.2023
LV23.08.2023
NL23.08.2023
PL23.08.2023
RO23.08.2023
RS23.08.2023
SM23.08.2023
NO23.11.2023
GR24.11.2023
IS23.12.2023
PT26.12.2023
Former [2024/20]AT23.08.2023
FI23.08.2023
HR23.08.2023
LT23.08.2023
LV23.08.2023
NL23.08.2023
PL23.08.2023
RS23.08.2023
SM23.08.2023
NO23.11.2023
GR24.11.2023
IS23.12.2023
PT26.12.2023
Former [2024/10]AT23.08.2023
FI23.08.2023
HR23.08.2023
LT23.08.2023
LV23.08.2023
NL23.08.2023
PL23.08.2023
RS23.08.2023
NO23.11.2023
GR24.11.2023
IS23.12.2023
PT26.12.2023
Former [2024/09]AT23.08.2023
FI23.08.2023
LT23.08.2023
NL23.08.2023
NO23.11.2023
GR24.11.2023
IS23.12.2023
Former [2024/08]LT23.08.2023
NL23.08.2023
NO23.11.2023
GR24.11.2023
Documents cited:Search[XI]US5480864  (TAJIMA MASAHIRO [JP], et al);
 [XI]WO0185100  (GEN HOSPITAL CORP [US], et al);
 [XI]US2002182729  (DICICCO-BLOOM EMANUEL [US], et al);
 [XI]US2004038888  (MERCER ALEX [SE], et al);
 [A]US2015104388  (COY DAVID H [US], et al);
International search[A]US5480864  (TAJIMA MASAHIRO [JP], et al);
 [A]WO0185100  (GEN HOSPITAL CORP [US], et al);
 [A]US2002182729  (DICICCO-BLOOM EMANUEL [US], et al);
 [A]US2004038888  (MERCER ALEX [SE], et al);
 [A]US2015104388  (COY DAVID H [US], et al);
by applicantUS4414148
 US4496542
 US4569789
 US4589071
 EP0188256
 US4659839
 US4671958
 US4680338
 US4699784
 US5152923
 US5480864
 US5698219
 US5753241
 US5925341
 US6039936
 US6120778
 WO0059863
 US6274150
 WO0185100
 US6335022
 US6375960
 US6413527
 US6419946
 US6461625
 US6464990
 US2002182729
 US6541018
 US6689371
 US2004038888
 US6902737
 US6998426
 US7314624
 US7476393
 US2015104388
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.